PKC Delta and Epsilon in Drug Targeting and Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 2212-3431|3|2|96-101

ISSN： 1872-2156

Source： Recent Patents on DNA & Gene Sequences, Vol.3, Iss.2, 2009-06, pp. : 96-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential of Microemulsions in Drug Delivery and Therapeutics: A Patent Review

By  

Recent Patents on Drug Delivery & Formulation, Vol. 2, Iss. 2, 2008-06 ,pp. : 136-144

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 2, 2010-01 ,pp. : 146-152

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 1, 2009-01 ,pp. : 1-16

Bentham Science Publishers

Access to resources Recommend Favorite

Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review

By  

Recent Patents on Drug Delivery & Formulation, Vol. 10, Iss. 2, 2016-08 ,pp. : 156-164

Bentham Science Publishers

Access to resources Recommend Favorite

PKC Inhibition and Diabetic Complications

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 2, 2008-06 ,pp. : 72-78

Bentham Science Publishers

Access to resources Recommend Favorite